CXCL13 and neoplasm: In TCGA bulk transcriptomes, we quantified the expression of two T cell programs of anti-tumor reactivity and effector function (‘CXCL13 T cell’ and ‘Cytotoxicity’ programs) that this study had identified as differentially active between MSI-H and MSS CRCs (Fig. 6f).